Texting your way to better glaucoma care: new trial tests daily reminders

NCT ID NCT07480577

Not yet recruiting Symptom relief Sponsor: Sakarya Yenikent State Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether daily SMS or WhatsApp reminders can help people with primary open-angle glaucoma stick to their eye-drop schedule. About 84 adults will be split into two groups: one gets the reminders plus weekly educational messages for 3 months, the other gets standard care. The goal is to see if the reminders improve medication adherence and lower eye pressure, which could slow vision loss.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: digital reminder system (SMS/WhatsApp messages)
What this could lead to: If it works, this could offer a simple, low-cost way to help glaucoma patients stick to their eye-drop routine and better control eye pressure.
What could go wrong: This is a small, early-stage trial with only 84 people over 3 months. The reminders may not improve adherence or eye pressure in the long run, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY OPEN ANGLE GLAUCOMA (POAG) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Medication Adherence open-angle glaucoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PRIMARY OPEN ANGLE GLAUCOMA (POAG)

More trials for these conditions

Other studies related to the condition(s) this trial covers.